NCT00966485View on ClinicalTrials.gov

Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting

NACompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Coronary Stenting
Interventions
DRUG

80 mg ASA dosing

DRUG

500 mg ASA dosing

Trial Locations (1)

55318

Namazi hospital, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT00966485 - Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting | Biotech Hunter | Biotech Hunter